Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids
Open Access
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 23 (12) , 1877-1887
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK047757)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01-HD057247)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01-HL059407)
This publication has 44 references indexed in Scilit:
- Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genomeMolecular Genetics and Metabolism, 2012
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia BNew England Journal of Medicine, 2011
- Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cellsGene Therapy, 2011
- Rapid, Simple, and Versatile Manufacturing of Recombinant Adeno-Associated Viral Vectors at ScaleHuman Gene Therapy, 2010
- Systematic Evaluation of AAV Vectors for Liver directed Gene Transfer in Murine ModelsMolecular Therapy, 2010
- The Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in MacaquesMolecular Therapy, 2010
- DNA Shuffling of Adeno-associated Virus Yields Functionally Diverse Viral ProgenyMolecular Therapy, 2008
- Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal modelProceedings of the National Academy of Sciences, 2007
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− miceNature Biotechnology, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004